Javascript must be enabled to continue!
Modern approaches to the essence and assessment of gut dysbiosis. Review
View through CrossRef
An imbalance, dysfunction, or disruption of the gut microbiota (GM) is increasingly recognized as an indicator of certain disease or poor health. Due to the complexity and individual variation in microbial communities, there is no gold standard for determining the presence or degree of this imbalance or disruption of the gut microbiota, although many studies refer to it as gut dysbiosis. The problem with the definition of intestinal dysbiosis is caused by the lack of a clear definition of a healthy intestinal microbiota. Several indices have been defined and applied to qualify the term «gut dysbiosis». According to the results of an extensive literature search, known indices of dysbiosis (ID) can be methodologically grouped into five categories: large‑scale profiling of bacterial markers, relevant taxon‑based methods, environmental classification, random prediction, combined α/β‑diversity. These methods for identifying and quantifying gut dysbiosis successfully capture differences between GM associated with specific conditions, diseases, or interventions, as well as that present in healthy individuals or at baseline (before intervention). Such indices can help to characterize diseases and adverse conditions, predict treatment outcomes, and provide information different from conventional alpha and beta estimates of microbial diversity. It should be kept in mind that dysbiosis is not a well‑defined condition and that indices of dysbiosis differ in methodological and clinical contexts, developed for different cohorts and to describe a variety of conditions. Current basic methods and principles related to the assessment of GM in a clinical context are highlighted, including the current use of dysbiosis indices, their calculation and indicators in the context of specific diseases and conditions. Dysbiosis indices are not separate measurements and should be interpreted in the context of clinical data. It should be remembered that the GM that characterizes a particular disease or intervention often changes due to disturbances in factors such as diet, medication, oxygen availability, or immune responses. In this case, ID is used as a diagnostic marker, but not necessarily as a predictor of the disease. However, the value of dysbiosis indices as simple tools to describe the differences between different gut microbial communities is important.
Publishing Company VIT-A-POL
Title: Modern approaches to the essence and assessment of gut dysbiosis. Review
Description:
An imbalance, dysfunction, or disruption of the gut microbiota (GM) is increasingly recognized as an indicator of certain disease or poor health.
Due to the complexity and individual variation in microbial communities, there is no gold standard for determining the presence or degree of this imbalance or disruption of the gut microbiota, although many studies refer to it as gut dysbiosis.
The problem with the definition of intestinal dysbiosis is caused by the lack of a clear definition of a healthy intestinal microbiota.
Several indices have been defined and applied to qualify the term «gut dysbiosis».
According to the results of an extensive literature search, known indices of dysbiosis (ID) can be methodologically grouped into five categories: large‑scale profiling of bacterial markers, relevant taxon‑based methods, environmental classification, random prediction, combined α/β‑diversity.
These methods for identifying and quantifying gut dysbiosis successfully capture differences between GM associated with specific conditions, diseases, or interventions, as well as that present in healthy individuals or at baseline (before intervention).
Such indices can help to characterize diseases and adverse conditions, predict treatment outcomes, and provide information different from conventional alpha and beta estimates of microbial diversity.
It should be kept in mind that dysbiosis is not a well‑defined condition and that indices of dysbiosis differ in methodological and clinical contexts, developed for different cohorts and to describe a variety of conditions.
Current basic methods and principles related to the assessment of GM in a clinical context are highlighted, including the current use of dysbiosis indices, their calculation and indicators in the context of specific diseases and conditions.
Dysbiosis indices are not separate measurements and should be interpreted in the context of clinical data.
It should be remembered that the GM that characterizes a particular disease or intervention often changes due to disturbances in factors such as diet, medication, oxygen availability, or immune responses.
In this case, ID is used as a diagnostic marker, but not necessarily as a predictor of the disease.
However, the value of dysbiosis indices as simple tools to describe the differences between different gut microbial communities is important.
.
Related Results
Gut Dysbiosis and Carbamazepine Differentially Impact Hippocampal Glial Response and Neurodegeneration in a Viral Infection-Induced Seizure Model
Gut Dysbiosis and Carbamazepine Differentially Impact Hippocampal Glial Response and Neurodegeneration in a Viral Infection-Induced Seizure Model
Abstract
Objective
Brain infection is an underrecognized global cause of epilepsy due to the ensuing neuroinflammation and neur...
British Food Journal Volume 46 Issue 12 1944
British Food Journal Volume 46 Issue 12 1944
1. The Committee have received a request from the Tea and Coffee Division for advice as to appropriate standards for liquid “coffee essences” including coffee and chicory essences,...
Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients
Multiple indicators of gut dysbiosis predict all-cause and cause-specific mortality in solid organ transplant recipients
Objective
Gut microbiome composition is associated with multiple diseases, but relatively little is known about its relationship with long-term outcome measures. While gut dysbiosi...
Microbiome dysbiosis in gallbladder cancer: A systemic review
Microbiome dysbiosis in gallbladder cancer: A systemic review
Gallbladder cancer (GBC) starts in the epithelial tissue (lining of the bile duct and gallbladder). It is a type of aggressive cancer called adenocarcinoma that can spread to other...
Microbiome dysbiosis in gallbladder cancer: A systemic review
Microbiome dysbiosis in gallbladder cancer: A systemic review
Gallbladder cancer (GBC) starts in the epithelial tissue (lining of the bile duct and gallbladder). It is a type of aggressive cancer called adenocarcinoma that can spread to other...
Maternal Gut Dysbiosis Alters Offspring Microbiota and Social Interactions
Maternal Gut Dysbiosis Alters Offspring Microbiota and Social Interactions
Increasing application of antibiotics changes the gut microbiota composition, leading to dysbiosis of the gut microbiota. Although growing evidence suggests the potential role of g...
A Fight Against Gut Dysbiosis: Dendritic‐cell Derived Hepcidin and its Healing Role and Prevention of Neurologic Disease Authors: Barbara Kania, Alexis Sotelo, Darren Ty, Jonathan J. Wisco, PhD
A Fight Against Gut Dysbiosis: Dendritic‐cell Derived Hepcidin and its Healing Role and Prevention of Neurologic Disease Authors: Barbara Kania, Alexis Sotelo, Darren Ty, Jonathan J. Wisco, PhD
Introduction
The human gut microbiome colonizes 70% of total microorganisms in the body and its composition can be impacted by several environmental factors, pa...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...

